ABSORPTION KINETICS OF ORAL AND RECTAL FLECAINIDE IN HEALTHY-SUBJECTS

被引:11
作者
LIEAHUEN, L
PROOST, JH
KINGMA, JH
MEIJER, DKF
机构
[1] STATE UNIV GRONINGEN,DEPT PHARMACOL & THERAPEUT,9700 AB GRONINGEN,NETHERLANDS
[2] ST ANTONIUS HOSP,DEPT CARDIOL,NIEUWEGEIN,NETHERLANDS
关键词
absorption; flecainide; healthy subjects; non-parenteral administration; pharmacokinetics; rectal administration;
D O I
10.1007/BF00278588
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The absorption kinetics of different pharmaceutical formulations of orally and rectally administered flecainide have been assessed in a cross-over study in 7 healthy volunteers. The subjects received single doses of flecainide after a washout period of at least one week. A tablet, an oral solution, a rectal solution and a 10 min i.v. infusion during 10 min each containing 100 mg flecainide were administered to the subjects in a randomized order. The mean absolute bioavailability was 98%, 78% and 81% for the rectal and oral solutions and the tablet. The lag time after administration of the oral solution was 0.33 h and it was 0.86 h after the tablet and 0.18 h after the rectal solution. The mean time to the peak serum concentration (tmax) after the rectal solution (0.67 h) was shorter than after either the tablet (4 h) or oral solution (1 h). The maximum serum concentration (Cmax) was 0.29 mg · 1-1 after the rectal solution, 0.14 mg · 1-1 after the tablet and 0.17 mg · 1-1 after the oral solution. All the volunteers showed significantly higher serum flecainide concentrations during the first 20 min of the absorption phase after rectal administration of 100 mg flecainide as a solution compared to its oral administration. In conclusion: based on the absolute bioavailability, Cmax, tmax, and lag times, rectal administration of flecainide solution gave a better absorption profile than after oral tablet or solution. © 1990 Springer-Verlag.
引用
收藏
页码:595 / 598
页数:4
相关论文
共 10 条
[1]   CLINICAL USEFULNESS OF FLECAINIDE ACETATE IN THE TREATMENT OF PAROXYSMAL SUPRAVENTRICULAR ARRHYTHMIAS [J].
CAMM, AJ ;
HELLESTRAND, KJ ;
NATHAN, AW ;
BEXTON, RS .
DRUGS, 1985, 29 :7-13
[2]  
CONARD GJ, 1979, CLIN PHARMACOL THER, V25, P218
[3]   METABOLISM OF FLECAINIDE [J].
CONARD, GJ ;
OBER, RE .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (05) :B41-B51
[4]   FLECAINIDE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC EFFICACY [J].
HOLMES, B ;
HEEL, RC .
DRUGS, 1985, 29 (01) :1-33
[5]   RECTAL ABSORPTION OF FLECAINIDE ACETATE [J].
LIEAHUEN, L ;
KINGMA, JH .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (01) :89-91
[6]  
LIEAHUEN L, 1989, THER DRUG MONIT, V6, P708
[7]   EPISODIC DRUG-TREATMENT IN THE MANAGEMENT OF PAROXYSMAL ARRHYTHMIAS [J].
MARGOLIS, B ;
DESILVA, RA ;
LOWN, B .
AMERICAN JOURNAL OF CARDIOLOGY, 1980, 45 (03) :621-626
[8]  
PROOST JH, 1987, THESIS U GRONINGEN N
[9]   INTRAVENOUS FLECAINIDE VERSUS VERAPAMIL FOR ACUTE CONVERSION OF PAROXYSMAL ATRIAL-FIBRILLATION OR FLUTTER TO SINUS RHYTHM [J].
SUTTORP, MJ ;
KINGMA, JH ;
LIEAHUEN, L ;
MAST, EG .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (11) :693-696
[10]  
TJANDRAMAGA T B, 1984, European Heart Journal, V5, P135